EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 262 filers reported holding EDITAS MEDICINE INC in Q3 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,596 | +3.3% | 461 | +9.0% | 0.00% | – |
Q2 2023 | $3,482 | +20.1% | 423 | +5.8% | 0.00% | – |
Q1 2023 | $2,900 | +9.0% | 400 | +33.3% | 0.00% | – |
Q4 2022 | $2,661 | +33.0% | 300 | +120.6% | 0.00% | – |
Q3 2022 | $2,000 | -50.0% | 136 | -61.1% | 0.00% | – |
Q2 2022 | $4,000 | +33.3% | 350 | +250.0% | 0.00% | – |
Q4 2021 | $3,000 | -85.7% | 100 | -80.0% | 0.00% | – |
Q3 2021 | $21,000 | -8.7% | 500 | +25.0% | 0.00% | – |
Q2 2021 | $23,000 | -20.7% | 400 | -42.9% | 0.00% | -100.0% |
Q1 2021 | $29,000 | -31.0% | 700 | +16.7% | 0.00% | 0.0% |
Q4 2020 | $42,000 | +147.1% | 600 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $17,000 | – | 600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |